Overview

Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye

Status:
Completed
Trial end date:
2019-12-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the efficacy and safety of CsA ophthalmic gel in the treatment of moderate to severe tear deficiency dry eye with different dosage, frequency and concentration, and to preliminarily determine the optimal dosage, frequency and concentration, so as to provide a theoretical basis for the design of follow-up clinical studies.
Phase:
Phase 2
Details
Lead Sponsor:
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Treatments:
Ophthalmic Solutions